Vertex Pharmaceuticals Incorporated shares owned by Oppenheimer Asset Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Oppenheimer Asset Management
from 13F filings
Historical chart of Oppenheimer Asset Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Oppenheimer Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Oppenheimer Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $11M | 23k | 465.08 |
| 2024-06-30 | $11M | 24k | 468.72 |
| 2024-03-31 | $6.0M | 14k | 418.01 |
| 2023-09-30 | $4.9M | 14k | 347.74 |
| 2023-06-30 | $5.0M | 14k | 351.93 |
| 2023-03-31 | $4.5M | 14k | 315.07 |
| 2022-12-31 | $4.4M | 15k | 288.78 |
| 2022-09-30 | $4.4M | 15k | 289.28 |
| 2022-06-30 | $3.8M | 14k | 281.65 |
| 2022-03-31 | $3.7M | 14k | 260.94 |
| 2021-12-31 | $2.9M | 15k | 200.00 |
| 2021-09-30 | $1.9M | 11k | 166.67 |
| 2021-06-30 | $6.1M | 29k | 214.29 |
| 2021-03-31 | $6.1M | 28k | 215.69 |
| 2020-12-31 | $6.6M | 28k | 236.31 |
| 2020-09-30 | $7.2M | 27k | 272.06 |
| 2020-06-30 | $7.6M | 26k | 290.29 |
| 2020-03-31 | $7.4M | 31k | 237.43 |
| 2019-12-31 | $7.4M | 34k | 218.66 |
| 2019-09-30 | $6.3M | 37k | 170.21 |
| 2019-06-30 | $9.0M | 49k | 185.19 |
| 2019-03-31 | $9.0M | 49k | 184.00 |
| 2018-12-31 | $8.7M | 53k | 165.84 |
| 2018-09-30 | $10M | 54k | 192.79 |
| 2018-06-30 | $8.8M | 52k | 170.26 |
| 2018-03-31 | $6.0M | 37k | 163.01 |
| 2017-12-31 | $3.9M | 26k | 152.00 |
| 2017-09-30 | $3.9M | 26k | 152.01 |
| 2017-06-30 | $1.9M | 15k | 129.03 |
| 2017-03-31 | $834k | 7.6k | 109.35 |
More positions owned by Oppenheimer Asset Management
View all positions for Oppenheimer Asset Management
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated